In this study, when predicting HER2-negative and HER2-positive status, tumor size and the retraction phenomenon assessed by ABVS were significant in both univariate and multivariate clinical-pathological analyses in the training set (p < 0.05). Here, ERBB2 is linked to neoplasm.